Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pancreum is a private U.S. medical device company focused on modular wearable systems for diabetes management and broader chronic-disease applications. The company is best known for developing a smartphone-controlled artificial pancreas concept built around a reusable controller called CoreMD and interchangeable modules for continuous glucose monitoring and drug delivery. Its diabetes portfolio has been described with product concepts including Genesis, Vigil, InsuLean, and Mine, aimed at combining sensing and automated insulin and potentially glucagon delivery in a lower-cost semi-disposable format. Based on available public information, Pancreum appears to remain a development-stage device company rather than a commercial-stage biotech or pharmaceutical business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pancreum.